Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Normal levels of natural cytotoxic cells against solid tumours in NK-deficient beige mice

Nature volume 290, pages 254–257 (1981)Cite this article

Abstract

Natural cell-mediated cytotoxicity (NCMC) capable of in vitro lysis of various lymphoid and non-lymphoid tumours has been described in mice and other species, including man1. NCMC has been proposed as a first level of defence against tumour growth in vivo, one which does not need the priming of the conventional immunological response1. The effector cells of NCMC seem to belong to a special category of lymphoid cells, being neither classical T or B cells nor macrophages1–5; natural killer (NK) cells have been proposed as the prototype effector cell1, although some heterogeneity among effector cells seems to exist, depending on the target cells used for testing4–10. Two main subgroups of NCMC effector cells have been defined: NK cells directed against lymphoma targets2,3,6,7 and natural cytotoxic (NC) cells directed against solid non-lymphoid tumours4,5,8–10. We describe here another distinction between the two systems: while NK activity is low in mice homozygous for the beige (bg) gene11–13 NC activity in spleen cell preparations from these animals is comparable with that observed in the appropriate controls (bg/+ and +/+ littermates). The bg syndrome of mice affects lysosome, melanosome and enzymatic functions and is a homologue of the Chediak–Higashi syndrome of man14. Defective NK activity in blood lymphocytes has also been reported in patients with Chediak–Higashi syndrome15. We also show that several mouse strains which have low NK activity, have normal or high levels of NC functions, expanding our previous observation that NC and NK cells are under distinct genetic control4,16.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Heberman, R. B. (ed.) Natural Cell-mediated Immunity Against Tumors (Academic, New York, 1980).

  2. Herberman, R. B. & Holden, H. T. Adv. Cancer Res. 27, 305–377 (1978).

    Article  CAS  Google Scholar 

  3. Kiessling, R. & Wigzell, H. Immun. Rev. 44, 165–208 (1979).

    Article  CAS  Google Scholar 

  4. Stutman, O., Paige, C. J. & Feo Figarella, E. J. Immun. 121, 1819–1826 (1978).

    CAS  Google Scholar 

  5. Paige, C. J., Feo Figarella, E., Cuttito, M. J., Cahan, A. & Stutman, O. J. Immun. 121, 1827–1835 (1978).

    CAS  Google Scholar 

  6. Kumar, V., Luevano, E. & Bennett, A. J. exp. Med. 150, 531–547 (1979).

    Article  CAS  Google Scholar 

  7. Burton, R. C. in Natural Cell-mediated Immunity Against Tumors, 19–35 (Academic, New York, 1980).

    Google Scholar 

  8. Stutman, O., Feo Figarella, E., Paige, C. J. & Lattime, E. C. in Natural Cell-mediated Immunity Against Tumors, 187–229 (Academic, New York, 1980).

    Google Scholar 

  9. Stutman, O. in Natural Cell-mediated Immunity Against Tumors, 231–240 (Academic, New York, 1980).

    Google Scholar 

  10. Stutman, O., Dien, P., Wisun, R. & Lattime, E. C. Proc. natn. Acad. Sci. U.S.A. 77, 2895–2898 (1980).

    Article  ADS  CAS  Google Scholar 

  11. Roder, J. & Duwe, A. Nature 278, 451–453 (1979).

    Article  ADS  CAS  Google Scholar 

  12. Roder, J. J. Immun. 123, 2168–2173 (1979).

    CAS  Google Scholar 

  13. Roder, J., Lohmann-Matthes, M. L., Domzig, W. & Wigzel, H. J. Immun. 123, 2174–2181 (1979).

    CAS  Google Scholar 

  14. Padgett, G. A., Holland, J. M., Prieur, D. J., Davis, W. C. & Gorhamn, J. R. in Animal Models for Biomedical Research Vol. 3, 1–12 (National Academy of Sciences, Washington DC, 1970).

    Google Scholar 

  15. Haliotis, T. et al. J. exp. Med. 151, 1039–1048 (1980).

    Article  CAS  Google Scholar 

  16. Stutman, O. & Cuttito, M. J. in Natural Cell-mediated Immunity Against Tumors, 431–442 (Academic, New York, 1980).

    Google Scholar 

  17. Lane, P. W. & Murphy, E. D. Genetics 72, 451–460 (1972).

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Brandt, E. J. & Swank, R. T. Am. J. Path. 82, 573–588 (1976).

    CAS  PubMed  Google Scholar 

  19. Talmadge, J. E., Meyers, K. M., Prieur, D. J. & Starkey, J. R. Nature 284, 622–624 (1980).

    Article  ADS  CAS  Google Scholar 

  20. Karre, K., Klein, G. O., Kiessling, R., Klein, G. & Roder, J. C. Nature 284, 624–626 (1980).

    Article  ADS  CAS  Google Scholar 

  21. Salomon, J. C., Creau-Goldberg, N. & Lynch, N. R. Cancer Immun. Immunther. 8, 67–70 (1980).

    Google Scholar 

  22. Stutman, O. in The Nude Mouse in Experimental and Clinical Research, 411–435 (Academic, New York, 1978).

    Google Scholar 

  23. Dent, P. B., Fish, L. W., White, J. F. & Good, R. A. Lab. Invest. 15, 1634–1642 (1966).

    CAS  Google Scholar 

  24. Murphy, E. D. in Biology of the Laboratory Mouse, 521–562 (McGraw-Hill, New York, 1966).

    Google Scholar 

  25. Heston, W. E. J. natn. Cancer Inst. 3, 79–82 (1942).

    Google Scholar 

  26. Strong, L. C. Yale J. Biol. Med. 25, 34–43 (1952).

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Stutman, O. Adv. Cancer Res. 22, 261–422 (1975).

    Article  CAS  Google Scholar 

  28. Boraschi, D. & Meltzer, M. E. J. Immun. 124, 1050–1053 (1980).

    CAS  PubMed  Google Scholar 

  29. Burnet, F. M. Prog. exp. Tumour. Res. 13, 1–27 (1970).

    Article  CAS  Google Scholar 

  30. Stutman, O. in The Handbook of Cancer Immunology Vol. 7, 1–25 (ed. Waters, H.) (Garland STPM, New York, 1980).

    Google Scholar 

  31. Durdik, J. M., Beck, B. N. & Henney, C. S. in Natural Cell-mediated Immunity Against Tumors, 37–46 (Academic, New York, 1980).

    Google Scholar 

  32. Brunda, M. J., Holden, H. T. & Heberman, R. B. in Natural Cell-mediated Immunity Against Tumors, 411–415 (Academic, New York, 1980).

    Google Scholar 

  33. Chun, M., Pasanen, V., Hammerling, U., Hammerling, G. F. & Hoffman, M. K. J. exp. Med. 150, 426–431 (1979).

    Article  CAS  Google Scholar 

  34. Young, W. W., Hakomori, S. I., Durkik, J. M. & Henney, C. S. J. Immun. 124, 199–201 (1980).

    CAS  PubMed  Google Scholar 

  35. Mahoney, K. H., Morse, S. S. & Morahan, P. S. Cancer Res. 40, 3934–3939 (1980).

    CAS  PubMed  Google Scholar 

  36. Riccardi, C., Santoni, A., Marlozzari, T. & Herberman, R. B. in Natural Cell-mediated Cytotoxicity Against Tumors, 1121–1139 (Academic, New York, 1980).

    Google Scholar 

  37. Mattes, M. J., Sharrow, S. O., Herberman, R. B. & Holden, H. T. J. Immun. 123, 2851–2890 (1979).

    CAS  Google Scholar 

  38. Koo, G. C., Jacobson, J. B., Hammerling, G. J. & Hammerling, U. J. Immun. 125, 1003–1006 (1980).

    CAS  Google Scholar 

  39. Stutman, O., Lattime, E. C. & Feo Figarella, E. Fedn Proc. (in the press).

Download references

Author information

Authors and Affiliations

  1. Cellular Immunobiology Section, Memorial Sloan-Kettering Cancer Center, New York, New York, 10021, USA

    Osias Stutman & Michael J. Cuttito

Authors
  1. Osias Stutman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J. Cuttito
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stutman, O., Cuttito, M. Normal levels of natural cytotoxic cells against solid tumours in NK-deficient beige mice. Nature 290, 254–257 (1981). https://doi.org/10.1038/290254a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/290254a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing